Results of cell culture binding assay of MBs to
αvβ3 integrin, endoglin,
and VEGFR2 with a parallel plate flow chamber. Phase-contrast
bright-field micrographs (original magnification, ×100; scale
bars, 20 μm) show binding of MBIntegrin,
MBEndoglin, and MBVEGFR2 (arrows) to cells
positive for angiogenic marker expression. Note that binding of all
three types of targeted MB was substantially higher to positive cells
than to negative control cells.